Nd 3) having at least one HIV primary care visit in the past year. Patients incarcerated .30 days in the past year or who could not 
complete the MedChemExpress 11089-65-9 survey due to mental, physical or language barriers were excluded from the study. Clinic exposure requirements ensured sufficient experience at the clinic to assess satisfaction over a Pleuromutilin price 12-month time frame. Due to limited study staff, we could not recruit all eligible patients concurrently. As such, we decided a priori to systematically sample patients from a list of eligible patients who had arrived at the clinic and checked in. Patients with the most recent check-in time at the time of study staff availability were approached for enrollment. The survey, available in English and Spanish, was administered prior to the HIV provider visit and took about 10 minutes to complete.estimated reliability of 0.67 (personal communication, Y. Lee, 2012). Retention in care. Since 2011, the US Department of Health and Human Services has recognized that patients with HIV suppression and a CD4 cell count well above the threshold for risk of opportunistic infection may need less intensive monitoring (e.g. clinicians may extend the interval for HIV RNA monitoring to every 6 months) [17]. Our definition of adequate versus inadequate retention in HIV care reflects clinical practice, where patients with stable clinical and immunological status can have follow-up intervals of 6 months (as opposed to the traditional 3? months). Retention in care was based on 1) the number of 3-month quarters with at least 1 completed HIV primary care visit in the year prior to survey completion (i.e. visit constancy) [18], and 2) HIV RNA and CD4 cell count results 1 year prior to survey completion 660 days. Because some participants may be seen at imprecise intervals, and the last interval was bounded by the enrollment date, we extended the first quarter interval by 2 weeks on the front end. Patients with adequate retention in care had 1) 3 or 4 quarters with an HIV primary care provider visit, or 2) at least 2 quarters with an HIV primary care provider visit and HIV suppression 1 year prior to survey completion, or 3) at least 2 quarters with an HIV primary care provider visit, and both a CD4 cell count 500 and not yet prescribed HAART 1 year prior to survey completion. Patients not meeting these criteria were classified as having inadequate retention in HIV care. HIV suppression. HIV suppression was defined as a plasma HIV RNA ,48 copies/mL630 days 15755315 from the date of survey completion. Lab values were obtained from electronic medical records. Other measures. Participants self-reported their gender, race, ethnicity, education, income, health status and incarceration history. The health status item was based on a validated, widely used question, “In general, how would you rate your overall health?” [10,19?1]. The 5-point response scale ranged from “poor” to “excellent.” Validated, single-item questions identified participants with possible depression, excessive alcohol use, and illegal or prescription drug abuse [22?4]. Electronic medical and administrative records provided data on age, appointments and laboratory values (CD4 cell count and HIV RNA).Statistical Analysis MeasuresThe survey instrument included 2 questions about overall care received in the clinic 1) “Overall, how do you feel about the care you got at this clinic in the past 12 months?” and 2) “Would you recommend 
this clinic to other patients with HIV?” These q.Nd 3) having at least one HIV primary care visit in the past year. Patients incarcerated .30 days in the past year or who could not complete the survey due to mental, physical or language barriers were excluded from the study. Clinic exposure requirements ensured sufficient experience at the clinic to assess satisfaction over a 12-month time frame. Due to limited study staff, we could not recruit all eligible patients concurrently. As such, we decided a priori to systematically sample patients from a list of eligible patients who had arrived at the clinic and checked in. Patients with the most recent check-in time at the time of study staff availability were approached for enrollment. The survey, available in English and Spanish, was administered prior to the HIV provider visit and took about 10 minutes to complete.estimated reliability of 0.67 (personal communication, Y. Lee, 2012). Retention in care. Since 2011, the US Department of Health and Human Services has recognized that patients with HIV suppression and a CD4 cell count well above the threshold for risk of opportunistic infection may need less intensive monitoring (e.g. clinicians may extend the interval for HIV RNA monitoring to every 6 months) [17]. Our definition of adequate versus inadequate retention in HIV care reflects clinical practice, where patients with stable clinical and immunological status can have follow-up intervals of 6 months (as opposed to the traditional 3? months). Retention in care was based on 1) the number of 3-month quarters with at least 1 completed HIV primary care visit in the year prior to survey completion (i.e. visit constancy) [18], and 2) HIV RNA and CD4 cell count results 1 year prior to survey completion 660 days. Because some participants may be seen at imprecise intervals, and the last interval was bounded by the enrollment date, we extended the first quarter interval by 2 weeks on the front end. Patients with adequate retention in care had 1) 3 or 4 quarters with an HIV primary care provider visit, or 2) at least 2 quarters with an HIV primary care provider visit and HIV suppression 1 year prior to survey completion, or 3) at least 2 quarters with an HIV primary care provider visit, and both a CD4 cell count 500 and not yet prescribed HAART 1 year prior to survey completion. Patients not meeting these criteria were classified as having inadequate retention in HIV care. HIV suppression. HIV suppression was defined as a plasma HIV RNA ,48 copies/mL630 days 15755315 from the date of survey completion. Lab values were obtained from electronic medical records. Other measures. Participants self-reported their gender, race, ethnicity, education, income, health status and incarceration history. The health status item was based on a validated, widely used question, “In general, how would you rate your overall health?” [10,19?1]. The 5-point response scale ranged from “poor” to “excellent.” Validated, single-item questions identified participants with possible depression, excessive alcohol use, and illegal or prescription drug abuse [22?4]. Electronic medical and administrative records provided data on age, appointments and laboratory values (CD4 cell count and HIV RNA).Statistical Analysis MeasuresThe survey instrument included 2 questions about overall care received in the clinic 1) “Overall, how do you feel about the care you got at this clinic in the past 12 months?” and 2) “Would you recommend this clinic to other patients with HIV?” These q.
